Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasma homocysteine thiolactone adducts associated with risk of coronary heart disease.

Clinica chimica acta; international journal of clinical chemistry - 1 Feb 2006

Yang Xu, Gao Yan, Zhou Jin, Zhen Yisong, Yang Yuejin, Wang Jizheng, Song Li, Liu Yuqing, Xu Haiyan, Chen Zaijia, Hui Rutai

Abstract excerpt

BACKGROUND: Homocysteine thiolactone adducts have been proposed as the culprit of homocysteine related cardiovascular diseases. We studied the association of these adducts in plasma, and the gene polymorphism of paraoxonase-2 with coronary heart disease. METHODS: 254 patients and 308 controls were recruited for the study. Homocysteine thiolactone adducts were determined with ELISA. The codon 311 polymorphism of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Aryldialkylphosphatase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Coronary Disease

Share to Enzyme-Linked Immunosorbent Assay

Share to Gene Frequency

Share to Homocysteine

Share to Polymorphism, Single Nucleotide

Share to Risk Factors

Source

Identifiers

PMID: 16111668
DOI: 10.1016/j.cccn.2005.07.007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasma homocysteine thiolactone adducts associated with risk of coronary heart disease.PMID 16111668Read ↗

Homocysteine Metabolites, Endothelial Dysfunction, and Cardiovascular DiseaseSemantic proximity Read ↗

The communal relation of MTHFR, MTR, ACE gene polymorphisms and hyperhomocysteinemia as conceivable risk of coronary artery disease.Semantic proximity Read ↗

Polymorphism of genes encoding homocysteine metabolism-related enzymes and risk for cardiovascular disease.Semantic proximity Read ↗

The correlation of homocysteine-thiolactonase activity of the paraoxonase (PON1) protein with coronary heart disease status.Semantic proximity Read ↗

Homocysteine Determinants and the Evidence to What Extent Homocysteine Determines the Risk of Coronary Heart DiseaseSemantic proximity Read ↗

The risk stratification of coronary vascular disease as linked to homocysteine, its modulating genes, genetic polymorphisms, conventional predictors, and with antihypertensive medicaments.Semantic proximity Read ↗

Association of homocysteine thiolactonase activity and PON1 polymorphisms with the severity of acute coronary syndrome.Semantic proximity Read ↗

Comparison of homocysteinemia and MTHFR 677CT polymorphism with Framingham Coronary Heart Risk Score.Semantic proximity Read ↗

[Homocysteine metabolism and its role in pathology].Semantic proximity Read ↗

Homocysteine concentration in coronary artery disease and severity of coronary lesions.Semantic proximity Read ↗

Correlation between C677T MTHFR gene polymorphism, plasma homocysteine levels and the incidence of CAD.Semantic proximity Read ↗

Homocysteine as a cause of ischemic heart disease: the door remains open.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.